Journal of Inorganic Materials ›› 2022, Vol. 37 ›› Issue (11): 1192-1202.DOI: 10.15541/jim20220435

Special Issue: 【生物材料】肿瘤治疗

• REVIEW • Previous Articles     Next Articles

Progresses on Hollow Periodic Mesoporous Organosilicas: Preparation and Application in Tumor Therapy

ZHANG Wenjun1(), ZHAO Xueying1, LÜ Jiangwei1(), QU Youpeng2   

  1. 1. School of Pharmacy, Harbin University of Commerce, Harbin 150076, China
    2. School of Life Science and Technology, Harbin Institute of Technology, Harbin 150080, China
  • Received:2022-07-23 Revised:2022-09-14 Published:2022-09-15 Online:2022-09-15
  • Contact: LÜ Jiangwei, associate professor. E-mail: pp198259@163.com
  • About author:ZHANG Wenjun (1982-), female, PhD, associate professor. E-mail: wenjun0501@126.com
  • Supported by:
    National Key Research and Development Program(MB20160087);Special Program for Young Talents of Harbin University of Commerce 2019(2019CX12)

Abstract:

With the development of mesoporous materials and biomedicine, hollow periodic mesoporous organosilicas (HPMOs), as a new type of mesoporous silicon material, stands out among many mesoporous materials because of its high specific surface area, high drug loading, good biocompatibility, multifunctional organic-inorganic hybrid framework, low cytotoxicity and biodegradability. Drug delivery systems based on HPMOs have been continuously developed, it provides a new strategy for tumor treatment. This article summarized the synthetic progress of HPMOs in recent years, briefly introduced the types of HPMOs, mainly expounded the hard template method, liquid interface assembly method and interface recombination-transformation method, and summarized its application in tumor therapy. Finally, challenges and future development trends as a drug carrier were prospected, in order to provide reference for the preparation and application of HPMOs in tumor therapy.

Key words: hollow periodic mesoporous organosilicas, hard template method, liquid-interface assembly method, interfacial recombination-transformation method, tumor therapy, review

CLC Number: